NDC 69097-664 – Icatibant
Icatibant Acetate 30 mg/3mL · Injection · Subcutaneous
Product NDC69097-664
Product details
- Brand name
- Icatibant
- Generic name
- Icatibant
- Labeler
- Cipla USA Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- ANDA · ANDA212446
- Marketed since
- July 13, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Bradykinin B2 Receptor Antagonist
Active ingredients
- Icatibant Acetate 30 mg/3mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 69097-664-34 | 1 SYRINGE, GLASS in 1 CARTON (69097-664-34) / 3 mL in 1 SYRINGE, GLASS | Jul 13, 2020 |
| 69097-664-68 | 3 SYRINGE, GLASS in 1 CARTON (69097-664-68) / 3 mL in 1 SYRINGE, GLASS | Jul 13, 2020 |
Other Icatibant products
- 62332-654 Icatibant Acetate 30 mg/3mL · Injection · Alembic Pharmaceuticals Inc.
- 46708-654 Icatibant Acetate 30 mg/3mL · Injection · Alembic Pharmaceuticals Limited
- 55150-351 Icatibant Acetate 30 mg/3mL · Injection, Solution · Eugia US LLC
- 63323-574 Icatibant Acetate 10 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 24201-207 Icatibant Acetate 30 mg/3mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0093-3066 Icatibant Acetate 10 mg/mL · Injection, Solution · Teva Pharmaceuticals USA, Inc.